Annovis Bio (ANVS)
(Delayed Data from NYSE)
$2.35 USD
+0.03 (1.29%)
Updated Sep 18, 2025 04:00 PM ET
After-Market: $2.36 +0.01 (0.43%) 7:58 PM ET
2-Buy of 5 2
F Value B Growth C Momentum D VGM
Fundamental Charts
About Dividend Yield (TTM)
Annovis Bio, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
ANVS 2.35 +0.03(1.29%)
Will ANVS be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for ANVS based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ANVS
All You Need to Know About Annovis Bio (ANVS) Rating Upgrade to Buy
ANVS: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for ANVS
Fell Below 20 Day Moving Average appears for ANVS after 2.11% move
20 Day Moving Average Support appears for ANVS after 0.84% move
Annovis Bio (ANVS) Unveils New Study on Buntanetap's New Crystal Form
20 Day Moving Average Support appears for ANVS after 3.63% move
Annovis Bio announces publication of new article in Biomolecules on buntanetap